Therapy of herpes virus infections in children

Richard J Whitley1

  • 1The University of Alabama at Birmingham, AL 35233, USA. RWhitley@peds.uab.edu

Insights

Pediatric viral infection treatments for HSV, VZV, and CMV have advanced. However, significant unmet needs remain for diseases like hepatitis B, C, and RSV, requiring new drug discovery.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Pharmacology

Background:

  • Viral infections pose a significant health burden in children.
  • Advances in antiviral therapies have improved outcomes for some common childhood viral illnesses.
  • Existing treatments do not address all pediatric viral diseases effectively.

Purpose of the Study:

  • To review the current state of antiviral treatments for children.
  • To identify pediatric viral infections with unmet medical needs.
  • To highlight areas for future drug discovery and development.

Main Methods:

  • Literature review of pediatric antiviral therapies.
  • Analysis of licensed and investigational treatments.
  • Identification of disease areas with limited therapeutic options.

Main Results:

  • Significant progress is noted for herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV) treatments in children.
  • Licensed influenza therapies are available but not detailed in this review.
  • Numerous viral diseases, including hepatitis B, hepatitis C, and respiratory syncytial virus (RSV), represent critical unmet needs in pediatric populations.

Conclusions:

  • While progress has been made, many pediatric viral infections still lack effective treatments.
  • Dedicated drug discovery efforts are crucial for addressing these unmet medical needs.
  • Future research should focus on developing novel therapies for diseases like hepatitis B, C, and RSV in children.

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...